Protein News and Research

RSS
Study indicates combining a hydrogen peroxide-based disinfectant with cellulosic copper nanoparticles lowers human coronaviruses' infectivity

Study indicates combining a hydrogen peroxide-based disinfectant with cellulosic copper nanoparticles lowers human coronaviruses' infectivity

Model for investigating the effect of mutations on the binding affinity of the SARS-CoV-2 RBD-ACE2 complex

Model for investigating the effect of mutations on the binding affinity of the SARS-CoV-2 RBD-ACE2 complex

Rutgers researchers use roundworms to unravel how cells communicate with one another

Rutgers researchers use roundworms to unravel how cells communicate with one another

Adaptive immunity against SARS-CoV-2 is persistent and robust in COVID-convalescent children

Adaptive immunity against SARS-CoV-2 is persistent and robust in COVID-convalescent children

A novel mRNA vaccine encoding delta RBD induces high neutralizing antibody titers

A novel mRNA vaccine encoding delta RBD induces high neutralizing antibody titers

IgG Fc glycosylation: A marker for severe COVID-19

IgG Fc glycosylation: A marker for severe COVID-19

Breast milk components show potent in vitro SARS-CoV-2 inhibition

Breast milk components show potent in vitro SARS-CoV-2 inhibition

INRS professor developing a glycoconjugate vaccine for melioidosis

INRS professor developing a glycoconjugate vaccine for melioidosis

UB-612 vaccine booster found to elicit high neutralizing antibody levels against SARS-CoV-2 Omicron

UB-612 vaccine booster found to elicit high neutralizing antibody levels against SARS-CoV-2 Omicron

Study evaluates humoral and cellular immune memory induced by different COVID-19 vaccines

Study evaluates humoral and cellular immune memory induced by different COVID-19 vaccines

Study explores favorable signatures for specific RNA motif recognition by SARS-CoV-2 nucleocapsid

Study explores favorable signatures for specific RNA motif recognition by SARS-CoV-2 nucleocapsid

New SARS-CoV-2 Omicron-Delta recombinant virus identified in the US

New SARS-CoV-2 Omicron-Delta recombinant virus identified in the US

Blood biomarker may uniquely aid prediction of dementia in Mexican Americans

Blood biomarker may uniquely aid prediction of dementia in Mexican Americans

Discovery could help explain why certain infections are hard to get rid of

Discovery could help explain why certain infections are hard to get rid of

Study finds that Omicron variant preferentially uses the endosome pathway through mutation in the spike protein

Study finds that Omicron variant preferentially uses the endosome pathway through mutation in the spike protein

Study evaluates mutation-induced SARS-CoV-2 spike protein fold stability

Study evaluates mutation-induced SARS-CoV-2 spike protein fold stability

Study finds fractionation of sulfated galactan from red alga can isolate its anti-SARS-CoV-2 properties

Study finds fractionation of sulfated galactan from red alga can isolate its anti-SARS-CoV-2 properties

Anti-spike SARS-CoV-2 antibody titer trends over 15 months in healthcare workers in Boston

Anti-spike SARS-CoV-2 antibody titer trends over 15 months in healthcare workers in Boston

Study identified multiple siRNAs spanning the SARS-CoV-2 genome with potent antiviral activity

Study identified multiple siRNAs spanning the SARS-CoV-2 genome with potent antiviral activity

Uptake of SARS-CoV-2 spike protein in human cerebrovascular cells

Uptake of SARS-CoV-2 spike protein in human cerebrovascular cells

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.